INS and type 1 diabetes mellitus: Despite the favorable results indicating potential efficacy of MSCs to preserve β-cell function in some T1D patients demonstrated by the higher C-peptide level, decreased insulin doses and improved HbA1c levels, there are still doubts on the long-term effectiveness of MSCs for the management of T1D (108, 109).